SOFWF.US SofWave Medical Ltd.

Healthcare Medical Devices USA Stocks
11.44 USD
Close of Nov 18, 2026
9.93 16.25
Market cap
USD 416M
P/E
39.4x
P/B
9.77x
ROE
24.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SOFWF.US undervalued?

Graham number

The Graham number of SofWave Medical Ltd. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SofWave Medical Ltd. fundamental analysis

No fundamental analysis for SofWave Medical Ltd. yet.

SofWave Medical Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SofWave Medical Ltd.

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-i…

Full company profile